VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Inclusion Criteria:

• Diagnosed atrophic vaginitis, lichen sclerosus, lichen simplex chronicus or lichenplanus
• Continuous vulvovaginal symptoms
• Access to smartphone and tablet, laptop or computer
• Access to a valid email address

Exclusion Criteria:

• Unable to provide informed consent
• Patient unable to apply topical device
• Allergy or intolerance to ingredients or excipients of the formulation of studiedproducts
• Systemic hormonal therapy started less than 30 days before baseline
• Systemic corticosteroids ongoing treatment or used within the last 30 days beforebaseline
• Ongoing topical HRT or corticosteroid treatment for the indication under investigation
• Topical HRT or corticosteroid treatment used for the indication under investigationwithin the last 30 days before baseline